CFDE Data Portal | Search GAGE1

	Label	Description
	GAGE1 associations Collection (Entity type)	Associations for GAGE1_associations
	GAGE1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GAGE1 Gene (Entity type)	ENSG00000205777 - G antigen 1
	GSE103510 STAT5 inhibition 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE185519 3 V 5 GILTERITINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 5 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE217085 L-25 HeLa 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

GAGE1 associations

Associations for GAGE1_associations

GAGE1 associations.tsv

A file from IDG as part of the Harmonizome project

GAGE1

ENSG00000205777 - G antigen 1

GSE103510 STAT5 inhibition 2 v 0 human dn

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 1 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE185519 3 V 5 GILTERITINIB HUMAN UP

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 2 v 6 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 5 v 6 human up

A Gene Set from LINCS

GSE217085 L-25 HeLa 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.